These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 23280789)

  • 1. The blood-brain barrier in health and disease.
    Daneman R
    Ann Neurol; 2012 Nov; 72(5):648-72. PubMed ID: 23280789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The blood-brain barrier: an overview: structure, regulation, and clinical implications.
    Ballabh P; Braun A; Nedergaard M
    Neurobiol Dis; 2004 Jun; 16(1):1-13. PubMed ID: 15207256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formation and maintenance of the BBB.
    Blanchette M; Daneman R
    Mech Dev; 2015 Nov; 138 Pt 1():8-16. PubMed ID: 26215350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral markers of blood-brain barrier damage.
    Marchi N; Cavaglia M; Fazio V; Bhudia S; Hallene K; Janigro D
    Clin Chim Acta; 2004 Apr; 342(1-2):1-12. PubMed ID: 15026262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and function of the blood-brain barrier.
    Abbott NJ; Patabendige AA; Dolman DE; Yusof SR; Begley DJ
    Neurobiol Dis; 2010 Jan; 37(1):13-25. PubMed ID: 19664713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tight junctions in brain barriers during central nervous system inflammation.
    Coisne C; Engelhardt B
    Antioxid Redox Signal; 2011 Sep; 15(5):1285-303. PubMed ID: 21338320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting.
    Correale J; Villa A
    Autoimmunity; 2007 Mar; 40(2):148-60. PubMed ID: 17453713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glia-induced reversible disruption of blood-brain barrier integrity and neuropathological response of the neurovascular unit.
    Willis CL
    Toxicol Pathol; 2011 Jan; 39(1):172-85. PubMed ID: 21189317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central nervous system penetration for small molecule therapeutic agents does not increase in multiple sclerosis- and Alzheimer's disease-related animal models despite reported blood-brain barrier disruption.
    Cheng Z; Zhang J; Liu H; Li Y; Zhao Y; Yang E
    Drug Metab Dispos; 2010 Aug; 38(8):1355-61. PubMed ID: 20427691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology of the blood-brain barrier: animal models and methods.
    Hawkins BT; Egleton RD
    Curr Top Dev Biol; 2008; 80():277-309. PubMed ID: 17950377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current concepts of blood-brain barrier development.
    Liebner S; Czupalla CJ; Wolburg H
    Int J Dev Biol; 2011; 55(4-5):467-76. PubMed ID: 21769778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How do immune cells overcome the blood-brain barrier in multiple sclerosis?
    Larochelle C; Alvarez JI; Prat A
    FEBS Lett; 2011 Dec; 585(23):3770-80. PubMed ID: 21550344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does VEGF secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight-junction proteins in central nervous system leukemia?
    Feng S; Huang Y; Chen Z
    Med Hypotheses; 2011 May; 76(5):618-21. PubMed ID: 21398042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial cell heterogeneity of blood-brain barrier gene expression along the cerebral microvasculature.
    Macdonald JA; Murugesan N; Pachter JS
    J Neurosci Res; 2010 May; 88(7):1457-74. PubMed ID: 20025060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging blood-brain barrier dysfunction in animal disease models.
    Wunder A; Schoknecht K; Stanimirovic DB; Prager O; Chassidim Y
    Epilepsia; 2012 Nov; 53 Suppl 6():14-21. PubMed ID: 23134491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of blood-brain barrier function by methamphetamine and cocaine.
    Dietrich JB
    Cell Tissue Res; 2009 Jun; 336(3):385-92. PubMed ID: 19350275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular damage in the central nervous system: a multifaceted role for vascular-derived TGF-β.
    Beck K; Schachtrup C
    Cell Tissue Res; 2012 Jan; 347(1):187-201. PubMed ID: 21850492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Looking at the blood-brain barrier: molecular anatomy and possible investigation approaches.
    Cardoso FL; Brites D; Brito MA
    Brain Res Rev; 2010 Sep; 64(2):328-63. PubMed ID: 20685221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The blood-brain barrier/neurovascular unit in health and disease.
    Hawkins BT; Davis TP
    Pharmacol Rev; 2005 Jun; 57(2):173-85. PubMed ID: 15914466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.
    Begley DJ
    Pharmacol Ther; 2004 Oct; 104(1):29-45. PubMed ID: 15500907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.